Tramadol Hydrochloride Tablet, Film Coated
Product Images NDC 0093-3301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 0093-3301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tramadol HCl Tablets A075977 Scored 1)

Structural Formula (Tramadol HCl Tablets A075977 Scored 1)
Chemical structure of tramadol hydrochloride showing the arrangement of functional groups and rings characteristic of this active ingredient.*
FDA Label Image

Figure 1 (Tramadol HCl Tablets A075977 Scored 2)

Figure 1 (Tramadol HCl Tablets A075977 Scored 2)
A pharmacokinetic graph showing concentration (ng/mL) versus time (hours) for Tramadol and its metabolite M1 with multiple and single doses. Four curves represent Tramadol (multiple and single dose) and M1 (multiple and single dose) concentrations over a 48-hour period.*
FDA Label Image

Figure 2 (Tramadol HCl Tablets A075977 Scored 3)

Figure 2 (Tramadol HCl Tablets A075977 Scored 3)
A line graph titled 'Protocol CAPSS-047' showing time to discontinuation due to nausea/vomiting. The x-axis represents days in double-blind (0 to 27 days), and the y-axis shows the percent discontinuing (0% to 55%). Two lines compare 10 days to 200 mg/day (solid line) and 16 days to 200 mg/day (dashed line). The graph indicates higher discontinuation rates for the 10-day group over time.*
FDA Label Image

Label 100s Scored (Tramadol HCl Tablets A075977 Scored 4)

Label 100s Scored (Tramadol HCl Tablets A075977 Scored 4)
Tramadol Hydrochloride Tablets, USP 50 mg film-coated oral tablets in a package of 100 tablets by Teva Pharmaceuticals USA, Inc. The label includes the NDC 0093-3301-01 and instructs pharmacists to dispense the accompanying Medication Guide with each patient. The label also contains usage, dosage, and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.